Extending these investigations to skeletal muscle, characterizing the involvement of LRRC8A in insulin resistance, including its interactions with glucose transporters and insulin signaling components, may uncover previously unrecognized mechanisms underlying systemic metabolic dysfunction. This evidence concerns the gene INS and Insulin resistance.